Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BIO-B●NYSE
HealthcareMedical - Devices
$389.98
$10.48(2.76%)
U.S. Market opens in 15h 50m

Bio-Rad Laboratories, Inc. (BIO-B)

Meyka AI Score

Z

Key Financials

Market Cap10.7B
P/E Ratio9.99
EPS (TTM)$-5.68
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$381.44
3 Months$379.45
1 Year Target$229.10

BIO-B Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Bio-Rad Laboratories, Inc. (NYSE: BIO-B) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Bio-Rad Laboratories, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BIO-B on the NYSE shows an RSI of 98.65, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $229.10 for the NYSE listing.

Key metrics behind Bio-Rad Laboratories, Inc.'s NYSE-traded stock include a P/E ratio of 9.99 and a market capitalization of 10.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIO-B on the NYSE.

Price Performance (NYSE: BIO-B)

1-Day Change
2.76%
5-Day Change
2.76%
1-Month Change
6.82%
3-Month Change
15.72%
6-Month Change
52.61%
Year-to-Date (YTD) Change
25.52%
1-Year Change
27.69%
3-Year Change
29.95%
5-Year Change
-45.86%
All-Time (Max) Change
2871.28%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

74,500 Employees
IPO DateSep 21, 1999
CountryUS
Actively Trading

Frequently Asked Questions